| 55235-6 |
Abnormal hemoglobin gene panel – Blood by Molecular genetics method |
| 72103-5 |
Acute and chronic leukemia fusion transcript panel – Blood or Tissue by Molecular genetics method |
| 72104-3 |
Acute and chronic leukemia fusion transcript per control transcript panel – Blood or Tissue by Molecular genetics method |
| 55234-9 |
Alpha thalassemia gene panel – Blood by Molecular genetics method |
| 76546-1 |
Breast cancer 10-year risk of distant recurrence panel by Prosigna |
| 77314-3 |
Chromosome analysis basic associated observations panel – Blood or Tissue by Cytogenetics |
| 81251-1 |
Complex genetic variant panel |
| 72727-1 |
Del(13)(q14) and del(17)(p13) in Blood or Tissue |
| 81250-3 |
Discrete genetic variant panel |
| 77313-5 |
DNA analysis discrete sequence variation basic associated observations panel – Blood or Tissue by Molecular genetics method |
| 94469-4 |
F2 gene.c.20210G>A and c.1691G>A panel – Blood or Tissue by Molecular genetics method |
| 48016-0 |
Genechip kit panel – Blood or Tissue by Molecular genetics method |
| 83011-7 |
Haplotype definition panel |
| 74885-5 |
HER2 panel – Tissue by FISH |
| 53783-7 |
HTT gene mutation panel – Blood or Tissue by Molecular genetics method |
| 64418-7 |
KIR genotyping panel – Blood or Tissue |
| 81247-9 |
Master HL7 genetic variant reporting panel |
| 82117-3 |
Medication usage implications panel |
| 93357-2 |
Monotypic plasma cell identification and risk stratification panel – Bone marrow by Molecular genetics method |
| 77018-0 |
Noninvasive prenatal fetal 13 and 18 and 21 aneuploidy panel – Plasma cell-free DNA by Sequencing |
| 77019-8 |
Noninvasive prenatal fetal 18 and 21 aneuploidy panel – Plasma cell-free DNA by Sequencing |
| 92901-8 |
Noninvasive prenatal fetal aneuploidy and microdeletion panel – Plasma cell-free DNA by Sequencing |
| 75547-0 |
Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
| 73967-2 |
Noninvasive prenatal fetal aneuploidy test panel – Plasma cell-free DNA |
| 78046-0 |
Pharmacogenomic analysis basic associated observations panel – Blood or Tissue |
| 82118-1 |
Pharmacogenomics result panel |
| 48014-5 |
Sequence variation panel – Blood or Tissue by Molecular genetics method |
| 48017-8 |
Sequencing methodology panel – Blood or Tissue by Molecular genetics method |
| 92005-8 |
Spinal muscular atrophy newborn screening panel |
| 81297-4 |
Structural variant panel |
| 52135-1 |
t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel – Blood or Tissue by Molecular genetics method |
| 81306-3 |
Variables that apply to the overall study |
